Despite the beneficial effects of MitoQ on neurodegenerative disease was reported in vivo , not all studies demonstrated such a link
Nine trials were conducted in participants with overweight and/or obesity (Reference Ahmed Al-Naggar, Osman and Abdulghani23,Reference Alperet, Rebello and Khoo24,Reference Basu, Betts and Mulugeta26,Reference Cardoso, Salgado and Cesar28,Reference Kobayashi, Kawano and Ukawa31,Reference Mousavi, Vafa and Neyestani35,Reference Nabi, Sedighinejad and Haghighi37,Reference Ohnaka, Ikeda and Maki38,Reference Wedick, Brennan and Sun44) and nine in healthy participants (Reference Ahmed Al-Naggar, Osman and Abdulghani23,Reference Hochkogler, Schweiger and Rust29Reference Lecoultre, Carrel and Egli32,Reference Revuelta-Iniesta and Al-Dujaili39,Reference Superko, Bortz and Williams40,Reference van Dusseldorp, Katan and van Vliet42,Reference Wedick, Brennan and Sun44)
Which mechanisms or molecules can be targeted in eryptosis signaling pathways
Composition : Ribonucleic Acid (RNA) 3800mg